25 XP   0   0   10

Harbin Medisan Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Medisan together

PenkeI guess you are interested in Harbin Medisan Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Harbin Medisan Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Harbin Medisan Pharmaceutical Co Ltd

I send you an email if I find something interesting about Harbin Medisan Pharmaceutical Co Ltd.

Quick analysis of Medisan (30 sec.)










What can you expect buying and holding a share of Medisan? (30 sec.)

How much money do you get?

How much money do you get?
¥0.19
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥6.48
Expected worth in 1 year
¥5.67
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥0.57
Return On Investment
5.7%

For what price can you sell your share?

Current Price per Share
¥9.87
Expected price per share
¥6.74 - ¥14.40
How sure are you?
50%

1. Valuation of Medisan (5 min.)




Live pricePrice per Share (EOD)

¥9.87

Intrinsic Value Per Share

¥-3.98 - ¥-0.96

Total Value Per Share

¥2.50 - ¥5.52

2. Growth of Medisan (5 min.)




Is Medisan growing?

Current yearPrevious yearGrowGrow %
How rich?$283.1m$292m-$8.8m-3.1%

How much money is Medisan making?

Current yearPrevious yearGrowGrow %
Making money$4.1m$48.4m-$44.2m-1,061.7%
Net Profit Margin2.9%37.1%--

How much money comes from the company's main activities?

3. Financial Health of Medisan (5 min.)




What can you expect buying and holding a share of Medisan? (5 min.)

Welcome investor! Medisan's management wants to use your money to grow the business. In return you get a share of Medisan.

What can you expect buying and holding a share of Medisan?

First you should know what it really means to hold a share of Medisan. And how you can make/lose money.

Speculation

The Price per Share of Medisan is ¥9.87. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Medisan.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Medisan, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥6.48. Based on the TTM, the Book Value Change Per Share is ¥-0.20 per quarter. Based on the YOY, the Book Value Change Per Share is ¥1.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.35 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Medisan.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.1%0.010.1%0.151.5%0.070.7%0.070.7%
Usd Book Value Change Per Share-0.03-0.3%-0.03-0.3%0.141.4%0.020.2%0.131.3%
Usd Dividend Per Share0.050.5%0.050.5%0.010.2%0.050.5%0.050.5%
Usd Total Gains Per Share0.020.2%0.020.2%0.161.6%0.070.7%0.171.8%
Usd Price Per Share1.88-1.88-2.87-1.87-1.90-
Price to Earnings Ratio143.05-143.05-18.79-60.33-50.25-
Price-to-Total Gains Ratio96.35-96.35-18.36-50.83-43.71-
Price to Book Ratio2.11-2.11-3.12-2.17-2.26-
Price-to-Total Gains Ratio96.35-96.35-18.36-50.83-43.71-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.36206
Number of shares734
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.050.05
Usd Book Value Change Per Share-0.030.02
Usd Total Gains Per Share0.020.07
Gains per Quarter (734 shares)14.3549.46
Gains per Year (734 shares)57.40197.84
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1140-834714256188
2280-165104285111386
3420-248161427167584
4560-330218569222782
5700-413275711278980
6840-4953328543331178
7979-5783899963891376
81119-66044611384441574
91259-74350312815001772
101399-82556014235561970

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.03.00.057.1%4.03.00.057.1%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%

Fundamentals of Medisan

About Harbin Medisan Pharmaceutical Co Ltd

Harbin Medisan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical product and medical devices in China. The company offers various drugs for nervous system, cardiovascular system, musculoskeletal system, systemic anti-infective, basic infusions, nutritional infusion, anti-tumor and immunomodulators, digestive tract, metabolism, etc. It also produces and sells cosmetics. Harbin Medisan Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Harbin, China.

Fundamental data was last updated by Penke on 2024-04-23 05:51:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is overpriced.

1.1. Profitability of Harbin Medisan Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Medisan earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Medisan to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 2.9% means that ¥0.03 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Harbin Medisan Pharmaceutical Co Ltd:

  • The MRQ is 2.9%. The company is making a profit. +1
  • The TTM is 2.9%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ2.9%TTM2.9%0.0%
TTM2.9%YOY37.1%-34.2%
TTM2.9%5Y12.0%-9.1%
5Y12.0%10Y14.1%-2.1%
1.1.2. Return on Assets

Shows how efficient Medisan is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Medisan to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.9% Return on Assets means that Medisan generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Harbin Medisan Pharmaceutical Co Ltd:

  • The MRQ is 0.9%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.9%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.9%TTM0.9%0.0%
TTM0.9%YOY11.4%-10.5%
TTM0.9%5Y5.7%-4.8%
5Y5.7%10Y7.4%-1.7%
1.1.3. Return on Equity

Shows how efficient Medisan is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Medisan to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.5% Return on Equity means Medisan generated ¥0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Harbin Medisan Pharmaceutical Co Ltd:

  • The MRQ is 1.5%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.5%TTM1.5%0.0%
TTM1.5%YOY16.7%-15.2%
TTM1.5%5Y8.0%-6.5%
5Y8.0%10Y10.2%-2.2%

1.2. Operating Efficiency of Harbin Medisan Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Medisan is operating .

  • Measures how much profit Medisan makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Medisan to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Harbin Medisan Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-15.9%+15.9%
TTM-5Y0.5%-0.5%
5Y0.5%10Y8.0%-7.6%
1.2.2. Operating Ratio

Measures how efficient Medisan is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.37 means that the operating costs are ¥1.37 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Harbin Medisan Pharmaceutical Co Ltd:

  • The MRQ is 1.372. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.372. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.372TTM1.3720.000
TTM1.372YOY1.463-0.092
TTM1.3725Y1.273+0.099
5Y1.27310Y1.218+0.054

1.3. Liquidity of Harbin Medisan Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Medisan is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.72 means the company has ¥2.72 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Harbin Medisan Pharmaceutical Co Ltd:

  • The MRQ is 2.716. The company is able to pay all its short-term debts. +1
  • The TTM is 2.716. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.716TTM2.7160.000
TTM2.716YOY2.660+0.057
TTM2.7165Y2.764-0.048
5Y2.76410Y2.881-0.117
1.3.2. Quick Ratio

Measures if Medisan is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Medisan to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.34 means the company can pay off ¥0.34 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Harbin Medisan Pharmaceutical Co Ltd:

  • The MRQ is 0.340. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.340. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.340TTM0.3400.000
TTM0.340YOY1.333-0.993
TTM0.3405Y0.904-0.564
5Y0.90410Y0.788+0.115

1.4. Solvency of Harbin Medisan Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Medisan assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Medisan to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.37 means that Medisan assets are financed with 37.4% credit (debt) and the remaining percentage (100% - 37.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Harbin Medisan Pharmaceutical Co Ltd:

  • The MRQ is 0.374. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.374. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.374TTM0.3740.000
TTM0.374YOY0.310+0.064
TTM0.3745Y0.297+0.077
5Y0.29710Y0.279+0.018
1.4.2. Debt to Equity Ratio

Measures if Medisan is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Medisan to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 60.0% means that company has ¥0.60 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Harbin Medisan Pharmaceutical Co Ltd:

  • The MRQ is 0.600. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.600. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.600TTM0.6000.000
TTM0.600YOY0.452+0.149
TTM0.6005Y0.434+0.167
5Y0.43410Y0.400+0.033

2. Market Valuation of Harbin Medisan Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Medisan generates.

  • Above 15 is considered overpriced but always compare Medisan to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 143.05 means the investor is paying ¥143.05 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Harbin Medisan Pharmaceutical Co Ltd:

  • The EOD is 103.437. Based on the earnings, the company is expensive. -2
  • The MRQ is 143.051. Based on the earnings, the company is expensive. -2
  • The TTM is 143.051. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD103.437MRQ143.051-39.614
MRQ143.051TTM143.0510.000
TTM143.051YOY18.791+124.260
TTM143.0515Y60.325+82.726
5Y60.32510Y50.253+10.072
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Harbin Medisan Pharmaceutical Co Ltd:

  • The EOD is 56.387. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 77.982. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 77.982. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD56.387MRQ77.982-21.595
MRQ77.982TTM77.9820.000
TTM77.982YOY-76.255+154.237
TTM77.9825Y6.246+71.736
5Y6.24610Y15.405-9.159
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Medisan is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Harbin Medisan Pharmaceutical Co Ltd:

  • The EOD is 1.523. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.106. Based on the equity, the company is underpriced. +1
  • The TTM is 2.106. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.523MRQ2.106-0.583
MRQ2.106TTM2.1060.000
TTM2.106YOY3.116-1.010
TTM2.1065Y2.168-0.062
5Y2.16810Y2.255-0.088
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Harbin Medisan Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.204-0.2040%1.026-120%0.137-249%0.926-122%
Book Value Per Share--6.4816.4810%6.685-3%6.179+5%5.607+16%
Current Ratio--2.7162.7160%2.660+2%2.764-2%2.881-6%
Debt To Asset Ratio--0.3740.3740%0.310+21%0.297+26%0.279+34%
Debt To Equity Ratio--0.6000.6000%0.452+33%0.434+38%0.400+50%
Dividend Per Share--0.3450.3450%0.108+219%0.351-2%0.334+3%
Eps--0.0950.0950%1.108-91%0.501-81%0.519-82%
Free Cash Flow Per Share--0.1750.1750%-0.273+256%0.097+80%0.185-5%
Free Cash Flow To Equity Per Share--0.1750.1750%-0.411+335%-0.062+135%0.397-56%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.957--------
Intrinsic Value_10Y_min---3.978--------
Intrinsic Value_1Y_max--0.056--------
Intrinsic Value_1Y_min---0.246--------
Intrinsic Value_3Y_max--0.052--------
Intrinsic Value_3Y_min---0.875--------
Intrinsic Value_5Y_max---0.091--------
Intrinsic Value_5Y_min---1.650--------
Market Cap3122769457.920-38%4321590682.5004321590682.5000%6594779041.500-34%4289930677.500+1%4361391831.643-1%
Net Profit Margin--0.0290.0290%0.371-92%0.120-76%0.141-79%
Operating Margin----0%-0.1590%0.005-100%0.080-100%
Operating Ratio--1.3721.3720%1.463-6%1.273+8%1.218+13%
Pb Ratio1.523-38%2.1062.1060%3.116-32%2.168-3%2.255-7%
Pe Ratio103.437-38%143.051143.0510%18.791+661%60.325+137%50.253+185%
Price Per Share9.870-38%13.65013.6500%20.830-34%13.550+1%13.776-1%
Price To Free Cash Flow Ratio56.387-38%77.98277.9820%-76.255+198%6.246+1149%15.405+406%
Price To Total Gains Ratio69.670-38%96.35396.3530%18.359+425%50.826+90%43.708+120%
Quick Ratio--0.3400.3400%1.333-74%0.904-62%0.788-57%
Return On Assets--0.0090.0090%0.114-92%0.057-84%0.074-88%
Return On Equity--0.0150.0150%0.167-91%0.080-82%0.102-86%
Total Gains Per Share--0.1420.1420%1.135-88%0.488-71%1.260-89%
Usd Book Value--283174199.411283174199.4110%292073218.441-3%269969232.596+5%244942396.170+16%
Usd Book Value Change Per Share---0.028-0.0280%0.142-120%0.019-249%0.128-122%
Usd Book Value Per Share--0.8940.8940%0.923-3%0.853+5%0.774+16%
Usd Dividend Per Share--0.0480.0480%0.015+219%0.048-2%0.046+3%
Usd Eps--0.0130.0130%0.153-91%0.069-81%0.072-82%
Usd Free Cash Flow--7647628.6267647628.6260%-11934654.640+256%4253878.751+80%8082139.619-5%
Usd Free Cash Flow Per Share--0.0240.0240%-0.038+256%0.013+80%0.026-5%
Usd Free Cash Flow To Equity Per Share--0.0240.0240%-0.057+335%-0.009+135%0.055-56%
Usd Market Cap430942185.193-38%596379514.185596379514.1850%910079507.727-34%592010433.495+1%601872072.767-1%
Usd Price Per Share1.362-38%1.8841.8840%2.875-34%1.870+1%1.901-1%
Usd Profit--4168985.8574168985.8570%48431246.861-91%21900148.904-81%22666341.887-82%
Usd Revenue--141921079.244141921079.2440%130520320.370+9%209419793.013-32%187233985.545-24%
Usd Total Gains Per Share--0.0200.0200%0.157-88%0.067-71%0.174-89%
 EOD+4 -4MRQTTM+0 -0YOY+13 -215Y+13 -2210Y+8 -27

3.2. Fundamental Score

Let's check the fundamental score of Harbin Medisan Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15103.437
Price to Book Ratio (EOD)Between0-11.523
Net Profit Margin (MRQ)Greater than00.029
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.340
Current Ratio (MRQ)Greater than12.716
Debt to Asset Ratio (MRQ)Less than10.374
Debt to Equity Ratio (MRQ)Less than10.600
Return on Equity (MRQ)Greater than0.150.015
Return on Assets (MRQ)Greater than0.050.009
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Harbin Medisan Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.334
Ma 20Greater thanMa 5010.481
Ma 50Greater thanMa 1009.912
Ma 100Greater thanMa 20011.385
OpenGreater thanClose9.800
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets3,276,788
Total Liabilities1,224,801
Total Stockholder Equity2,040,671
 As reported
Total Liabilities 1,224,801
Total Stockholder Equity+ 2,040,671
Total Assets = 3,276,788

Assets

Total Assets3,276,788
Total Current Assets1,623,659
Long-term Assets1,653,129
Total Current Assets
Cash And Cash Equivalents 1,202,646
Short-term Investments 91,252
Net Receivables 111,948
Inventory 161,160
Other Current Assets 4,548
Total Current Assets  (as reported)1,623,659
Total Current Assets  (calculated)1,571,556
+/- 52,104
Long-term Assets
Property Plant Equipment 882,449
Goodwill 500
Intangible Assets 71,670
Long-term Assets  (as reported)1,653,129
Long-term Assets  (calculated)954,619
+/- 698,510

Liabilities & Shareholders' Equity

Total Current Liabilities597,734
Long-term Liabilities627,067
Total Stockholder Equity2,040,671
Total Current Liabilities
Short Long Term Debt 220,223
Accounts payable 120,839
Other Current Liabilities 14,496
Total Current Liabilities  (as reported)597,734
Total Current Liabilities  (calculated)355,559
+/- 242,175
Long-term Liabilities
Long term Debt 417,785
Capital Lease Obligations Min Short Term Debt5,145
Long-term Liabilities  (as reported)627,067
Long-term Liabilities  (calculated)422,930
+/- 204,138
Total Stockholder Equity
Retained Earnings 570,719
Total Stockholder Equity (as reported)2,040,671
Total Stockholder Equity (calculated)570,719
+/- 1,469,952
Other
Capital Stock316,600
Common Stock Shares Outstanding 316,600
Net Invested Capital 2,678,679
Net Working Capital 1,025,925
Property Plant and Equipment Gross 1,479,349



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
1,166,188
2,183,746
2,513,555
2,672,124
2,482,761
3,065,517
3,276,788
3,276,7883,065,5172,482,7612,672,1242,513,5552,183,7461,166,188
   > Total Current Assets 
339,752
1,358,989
1,640,798
1,685,592
1,440,160
1,427,194
1,623,659
1,623,6591,427,1941,440,1601,685,5921,640,7981,358,989339,752
       Cash And Cash Equivalents 
128,849
354,658
451,686
471,492
661,448
529,833
1,202,646
1,202,646529,833661,448471,492451,686354,658128,849
       Short-term Investments 
0
0
104,909
696,725
360,791
581,676
91,252
91,252581,676360,791696,725104,90900
       Net Receivables 
89,726
178,303
208,940
219,521
155,086
133,622
111,948
111,948133,622155,086219,521208,940178,30389,726
       Inventory 
89,141
147,715
183,940
214,335
186,512
156,548
161,160
161,160156,548186,512214,335183,940147,71589,141
       Other Current Assets 
32,036
29,312
40,103
58,449
70,708
25,515
4,548
4,54825,51570,70858,44940,10329,31232,036
   > Long-term Assets 
826,436
824,757
868,344
986,532
1,042,601
1,638,323
1,653,129
1,653,1291,638,3231,042,601986,532868,344824,757826,436
       Property Plant Equipment 
722,601
721,716
725,711
806,691
867,290
925,345
882,449
882,449925,345867,290806,691725,711721,716722,601
       Goodwill 
9,436
9,436
9,436
9,436
9,436
9,436
500
5009,4369,4369,4369,4369,4369,436
       Intangible Assets 
51,765
50,639
72,567
70,053
66,417
62,504
71,670
71,67062,50466,41770,05372,56750,63951,765
       Other Assets 
38,560
22,967
28,836
76,949
84,544
36,536
0
036,53684,54476,94928,83622,96738,560
> Total Liabilities 
358,014
348,800
543,783
820,439
691,183
949,044
1,224,801
1,224,801949,044691,183820,439543,783348,800358,014
   > Total Current Liabilities 
271,953
266,624
447,191
723,295
588,840
536,614
597,734
597,734536,614588,840723,295447,191266,624271,953
       Short-term Debt 
106,000
0
58,000
180,000
0
0
0
000180,00058,0000106,000
       Short Long Term Debt 
106,000
0
58,000
180,000
269,782
270,280
220,223
220,223270,280269,782180,00058,0000106,000
       Accounts payable 
97,036
77,980
43,959
68,130
90,011
105,162
120,839
120,839105,16290,01168,13043,95977,98097,036
       Other Current Liabilities 
41,254
74,256
151,362
153,504
99,588
49,078
14,496
14,49649,07899,588153,504151,36274,25641,254
   > Long-term Liabilities 
86,062
82,176
96,592
97,144
102,343
412,430
627,067
627,067412,430102,34397,14496,59282,17686,062
       Capital Lease Obligations 
0
0
0
0
10,868
8,026
5,145
5,1458,02610,8680000
       Other Liabilities 
86,062
82,176
96,925
97,144
102,343
199,562
0
0199,562102,34397,14496,92582,17686,062
> Total Stockholder Equity
808,174
1,834,947
1,947,459
1,832,696
1,775,281
2,101,449
2,040,671
2,040,6712,101,4491,775,2811,832,6961,947,4591,834,947808,174
   Common Stock
158,300
211,067
316,600
316,600
316,600
316,600
0
0316,600316,600316,600316,600211,067158,300
   Retained Earnings 
355,971
457,896
554,535
529,187
471,772
797,940
570,719
570,719797,940471,772529,187554,535457,896355,971
   Capital Surplus 0000000
   Treasury Stock0000000
   Other Stockholders Equity 0000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,188,984
Cost of Revenue-445,220
Gross Profit743,765743,765
 
Operating Income (+$)
Gross Profit743,765
Operating Expense-1,175,329
Operating Income13,655-431,564
 
Operating Expense (+$)
Research Development103,521
Selling General Administrative519,494
Selling And Marketing Expenses-
Operating Expense1,175,329623,016
 
Net Interest Income (+$)
Interest Income28,103
Interest Expense-22,922
Other Finance Cost-1,148
Net Interest Income4,033
 
Pretax Income (+$)
Operating Income13,655
Net Interest Income4,033
Other Non-Operating Income Expenses-
Income Before Tax (EBT)76,57213,655
EBIT - interestExpense = -22,922
68,997
91,919
Interest Expense22,922
Earnings Before Interest and Taxes (EBIT)-99,494
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax76,572
Tax Provision-11,221
Net Income From Continuing Ops65,35065,350
Net Income68,997
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--4,033
 

Technical Analysis of Medisan
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Medisan. The general trend of Medisan is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Medisan's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Harbin Medisan Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 14.02 < 14.09 < 14.40.

The bearish price targets are: 9.28 > 9.2 > 6.74.

Tweet this
Harbin Medisan Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Harbin Medisan Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Harbin Medisan Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Harbin Medisan Pharmaceutical Co Ltd. The current macd is 0.02096976.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Medisan price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Medisan. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Medisan price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Harbin Medisan Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartHarbin Medisan Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Harbin Medisan Pharmaceutical Co Ltd. The current adx is 25.27.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Medisan shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Harbin Medisan Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Harbin Medisan Pharmaceutical Co Ltd. The current sar is 13.59.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Harbin Medisan Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Harbin Medisan Pharmaceutical Co Ltd. The current rsi is 45.33. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Harbin Medisan Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartHarbin Medisan Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Harbin Medisan Pharmaceutical Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Medisan price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Harbin Medisan Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartHarbin Medisan Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Harbin Medisan Pharmaceutical Co Ltd. The current cci is -64.76088785.

Harbin Medisan Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartHarbin Medisan Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Harbin Medisan Pharmaceutical Co Ltd. The current cmo is -15.03467172.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Harbin Medisan Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartHarbin Medisan Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Harbin Medisan Pharmaceutical Co Ltd. The current willr is -88.4765625.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Harbin Medisan Pharmaceutical Co Ltd Daily Williams %R ChartHarbin Medisan Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Harbin Medisan Pharmaceutical Co Ltd.

Harbin Medisan Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Harbin Medisan Pharmaceutical Co Ltd. The current atr is 0.6872044.

Harbin Medisan Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartHarbin Medisan Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Harbin Medisan Pharmaceutical Co Ltd. The current obv is 104,409,630.

Harbin Medisan Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartHarbin Medisan Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Harbin Medisan Pharmaceutical Co Ltd. The current mfi is 27.60.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Harbin Medisan Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartHarbin Medisan Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Harbin Medisan Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-19ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-26STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Harbin Medisan Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Harbin Medisan Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.334
Ma 20Greater thanMa 5010.481
Ma 50Greater thanMa 1009.912
Ma 100Greater thanMa 20011.385
OpenGreater thanClose9.800
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Medisan with someone you think should read this too:
  • Are you bullish or bearish on Medisan? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Medisan? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Harbin Medisan Pharmaceutical Co Ltd

I send you an email if I find something interesting about Harbin Medisan Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Harbin Medisan Pharmaceutical Co Ltd.

Receive notifications about Harbin Medisan Pharmaceutical Co Ltd in your mailbox!